Rhythmic Haptic Cueing Using Wearable Devices as Physiotherapy for Huntington Disease: Case Study

Theodoros Georgiou1, Riasat Islam2, Simon Holland2

  • 1School of Mathematical and Computer Sciences, Heriot-Watt University, Edinburgh, United Kingdom.

Insights

Rhythmic haptic cueing (RHC) may improve walking in Huntington disease (HD). This case study showed improved gait coordination and limb control, suggesting potential therapeutic benefits for HD patients.

Area of Science:

  • Neurology
  • Biomedical Engineering
  • Rehabilitation Science

Background:

  • Huntington disease (HD) is a fatal genetic disorder causing progressive brain cell death and severe motor impairments, including gait instability.
  • Current treatments for HD do not offer a cure, necessitating research into supportive therapies.
  • Rhythmic haptic cueing (RHC), delivered via wearable devices, offers a non-intrusive method to improve gait and coordination in neurological conditions.

Purpose of the Study:

  • To investigate the applicability and efficacy of RHC in improving gait coordination and limb control in individuals with Huntington disease.
  • To assess the potential of RHC as a therapeutic intervention to delay symptom onset or reduce severity, thereby enhancing quality of life.

Main Methods:

  • A case study employing a repeated-measures design with three conditions: baseline (no cues), during RHC, and post-RHC.
  • Quantitative data collection using wearable devices to measure gait kinematics.
  • Qualitative data collection through in-depth interviews with expert physiotherapists observing the intervention.

Main Results:

  • Physiotherapists observed notable improvements in the participant's walking kinematics when using RHC compared to baseline.
  • Observed kinematic improvements persisted even after the haptic cues were removed, suggesting potential lasting effects.
  • Quantitative gait data corroborated the qualitative observations of improved movement coordination.

Conclusions:

  • Rhythmic haptic cueing shows promise as an immediate, potentially therapeutic intervention for enhancing walking kinematics in individuals with Huntington disease.
  • The findings from this case study warrant further investigation into RHC as a viable supportive therapy for HD management.
Abstract

Related Concept Videos